Skip to main content
. 2004 Dec;78(24):13687–13696. doi: 10.1128/JVI.78.24.13687-13696.2004

FIG. 8.

FIG. 8.

Antiviral efficacy of HIV-1-specific siRNAs for HIV-1 YU-2 infection in human MDMs. Primary human macrophages were transfected with siRNAs and then infected with HIV-1 YU-2 (MOI, 0.1 pg of p24/cell). HIV-1 p24 antigen levels in culture supernatants were measured at 2 and 9 dpi. The data show the levels of viral production in macrophages infected with HIV-1 YU-2 and not transfected with siRNA (YU-2) and in macrophages infected with HIV-1 YU-2 and transfected with HIV-1-specific siRNAs 5, 6, and 8 (YU-2 + HIV-1-specific siRNA). The means of three experiments and the standard deviations are indicated.